NEW YORK, March 7—Biotechnology specialist Noonan Russo Communications, acquired by Havas in July of last year, is merhing with the holding company’s PResence Euro RSCG unit to create what Euro RSCG Healthcare co-chairman Ron Pantello describes as “a new, truly differentiated communications agency” called Noonan Russo Presence Euro RSCG.
The new company offers experience in corporate, media, and investor relations, and marketing communications services, and can leverage the global capabilities of Euro RSCG Healthcare, the world’s third-largest healthcare network, with 44 agencies serving healthcare clients in 17 countries throughout Europe, North America, Latin America, and Asia Pacific.
Says Pantello, “We believe healthcare companies—from entrepreneurial to multinational—need and value a holistic view of their company, their communications, and the healthcare environment. Together Noonan/Russo and PResence will address that need and deliver on their promise of focused and expert counsel backed by flexible service packages.”
Noonan/Russo reported 2000 revenues of around $14 million. PResence has revenues of around $5 million.
According to Susan Noonan, who will serve as president, “This combination gives us and our clients expanded international access to new products and skill sets that are essential to meeting
the diverse and fast moving needs of the healthcare sector, ranging from corporate consulting and investor relations to product marketing and public affairs. We are a global communications consultancy. Our mission is to build our client’s business through an innovative, integrated, multidisciplinary process that provides companies with a clear commercialization pathway to success.”
“Noonan/Russo is an ideal strategic partner for us,” commented Nancy Rueth, who was president of PResence and will now serve as executive vice president of Noonan Russo Presence. “Noonan Russo Presence has a combined expertise in healthcare categories and communications competencies that forms a formidable knowledge resource for the healthcare industry. We offer biotechnology companies and pharmaceutical companies alike terrific access to health, consumer and professional audiences, third party groups and the media—both on-line and off-line—that they need to reach.”
The firm will have 120 employees in its four offices located in New York, San Francisco, San Diego, and London. Its client roster includes Eli Lilly & Co., Pharmacia, MedImmune, Serono, deCODE Genetics, Trimeris, and Centagenetix.